Stock Price

The auto supplier's 2025 results show a profitable balance between legacy tech and EV innovation, fueled by post-acquisition operational discipline.

After orchestrating a major divestiture, Stoneridge's long-time CFO Matt Horvath resigns, ushering in a new era for the transportation tech firm.

CEO Andy Silvernail will detail the packaging giant's split and future strategy amid mixed earnings, setting high stakes for his upcoming investor address.

With strong 2025 results as a tailwind, Agilent's upcoming Q1 earnings report will test its ambitious guidance and signal trends for the life sciences industry.

Celanese completes a key divestiture to tackle its massive debt, while buyer Element Solutions bolsters its high-growth electronics portfolio.

TeraWulf is acquiring old industrial sites in KY and MD, adding massive power capacity for the AI boom while aiming to stabilize regional energy grids.

Morningstar's $365M CRSP acquisition and extended Vanguard pact positions it to challenge index titans, promising a new era for low-cost investing.

Atlantic International hires veteran CFO Kevin J. Murphy to integrate its massive Circle8 acquisition and navigate a complex financial landscape.

Bolstered by a massive capital infusion and strong investor demand, Vaxcyte is set to accelerate its broad-spectrum vaccine pipeline against market leaders.

Investors sue Bitdeer, alleging the company misled them about its advanced crypto mining chip's progress, leading to significant stock price declines.

Devonian appoints veteran CFO Dennis Turpin and corrects stock options, signaling a strategic shift as it aims to overcome financial hurdles and advance its pipeline.

With home health aide costs nearing $78,000 annually, families face a financial maze. Learn key strategies for creating a realistic budget for senior care.

Smashing its target, Hamilton Lane's new fund highlights intense investor appetite for assets powering AI, logistics, and the energy transition.

Amid strategic uncertainty after a rejected takeover, STAAR Surgical appoints two veteran executives as interim co-CEOs while launching a global search.

Tenet Healthcare finalizes a multi-billion dollar deal with CommonSpirit, regaining full control of Conifer and signaling major investments in AI and automation.

After its stock plummeted post-IPO, Chinese health-tech firm POMDOCTOR faces a Nasdaq delisting threat, forcing a reckoning with its massive losses.

Facing default, The Cannabist Company secures a short-term forbearance, highlighting a systemic liquidity crisis threatening the US cannabis industry.

The oil & gas operator is one step from a NYSE listing, promising a 13.5% dividend yield and a major consolidation play in the mature assets market.

Amid a recovering SPAC market, K2 Capital's successful $138M offering launches an ambitious search for targets in robotics, AI, and nuclear energy.

Shareholders grant VivoPower a sweeping mandate to overhaul its structure and pursue an AI data center strategy, despite lingering market skepticism.